These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7871155)

  • 1. The equal effectiveness ratio: a quantitative approach to the evaluation of compounds for boron neutron capture therapy.
    Bond VP; Laster BH; Wielopolski L
    Radiat Res; 1995 Mar; 141(3):287-93. PubMed ID: 7871155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radiation biology of boron neutron capture therapy.
    Coderre JA; Morris GM
    Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo simulation of the biological effects of boron neutron capture irradiation with d(14)+Be neutrons in vitro.
    Pöller F; Sauerwein W
    Radiat Res; 1995 Apr; 142(1):98-106. PubMed ID: 7899565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
    Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
    Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological considerations concerning the development of compounds for boron neutron capture therapy.
    Gabel D
    Strahlenther Onkol; 1993 Jan; 169(1):65-70. PubMed ID: 8434342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.
    Hiratsuka J; Fukuda H; Kobayashi T; Kanda K; Honda C; Ichihashi M; Mishima Y
    Radiat Med; 1996; 14(5):257-63. PubMed ID: 8988505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
    Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
    Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations.
    Nguyen T; Brownell GL; Holden SA; Kahl S; Miura M; Teicher BA
    Radiat Res; 1993 Jan; 133(1):33-40. PubMed ID: 8434111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model.
    Coderre JA; Morris GM; Kalef-Ezra J; Micca PL; Ma R; Youngs K; Gordon CR
    Radiat Res; 1999 Aug; 152(2):113-8. PubMed ID: 10409319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
    Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.